Oncology Pharma Inc

PINK:ONPH USA Biotechnology

Market Cap

$3.80K

Market Cap Rank

#51429 Global

#16127 in USA

Share Price

$0.00

Change (1 day)

+0.00%

52-Week Range

All Time High

$2600.00

Oncology Pharma Inc - Asset Resilience Ratio

Latest as of June 2001: 10.77%

Oncology Pharma Inc (ONPH) has an Asset Resilience Ratio of 10.77% as of June 2001. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$499.00K

Cash + Short-term Investments

Total Assets

$4.63 Million

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2000)

This chart shows how Oncology Pharma Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Oncology Pharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$499.00K	10.77%
Total Liquid Assets	$499.00K	10.77%

Asset Resilience Insights

Moderate Liquidity: Oncology Pharma Inc has 10.77% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.